Estrogen has a variety of genetic and epigenetic changes in the occurrence and development of thyroid cancer, in which activation of phosphatidylinositol-3 kinase (PI3K)/AKT signal pathway and mitogen-activated protein kinases (MAPK) signal pathway due to mutations are critical in cancer progression. This evidence concerns the gene PIK3CB and thyroid cancer.